Inventor
ASKEW BEN C
US49 patents
⚠️ This page may combine multiple inventors who share the name “ASKEW BEN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCIFLUOR LIFE SCIENCES INC
16 patentsUS9572801B2Feb 21, 2017
Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof
SCIFLUOR LIFE SCIENCES INC22 citations93
US9717729B2Aug 1, 2017
Fluorinated integrin antagonists
SCIFLUOR LIFE SCIENCES INC14 citations92
US9518053B2Dec 13, 2016
Fluorinated integrin antagonists
SCIFLUOR LIFE SCIENCES INC16 citations92
US9266884B2Feb 23, 2016
Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-y1)-3-arylpropanoic acid derivatives
SCIFLUOR LIFE SCIENCES INC14 citations92
US10301307B2May 28, 2019
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
SCIFLUOR LIFE SCIENCES INC5 citations84
US10155758B2Dec 18, 2018
Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
SCIFLUOR LIFE SCIENCES INC5 citations84
US10106537B2Oct 23, 2018
Fluorinated integrin antagonists
SCIFLUOR LIFE SCIENCES INC7 citations84
US9802933B2Oct 31, 2017
Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
SCIFLUOR LIFE SCIENCES INC7 citations84
US9790222B2Oct 17, 2017
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
SCIFLUOR LIFE SCIENCES INC10 citations84
US9593114B2Mar 14, 2017
Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
SCIFLUOR LIFE SCIENCES INC8 citations84
US9662331B2May 30, 2017
3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones
SCIFLUOR LIFE SCIENCES INC2 citations73
US10676437B2Jun 9, 2020
Fluorinated 4-(substituted amino)phenyl carbamate derivatives
SCIFLUOR LIFE SCIENCES INC1 citations62
US10308647B2Jun 4, 2019
Fused imidazole derivatives as IDO/TDO inhibitors
SCIFLUOR LIFE SCIENCES INC1 citations62
US10118929B2Nov 6, 2018
Nonanoic and decanoic acid derivatives and uses thereof
SCIFLUOR LIFE SCIENCES INC0 citations52
US9624169B2Apr 18, 2017
Aryl- and heteroaryl-pyrrolidine-2-carboxamide compounds
SCIFLUOR LIFE SCIENCES INC0 citations52
US9216985B2Dec 22, 2015
3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones
SCIFLUOR LIFE SCIENCES INC1 citations52
KALA PHARMACEUTICALS INC
16 patentsUS9353122B2May 31, 2016
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC14 citations92
US9877970B2Jan 30, 2018
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC4 citations84
US9353123B2May 31, 2016
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC3 citations84
US10758539B2Sep 1, 2020
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC1 citations73
US10398703B2Sep 3, 2019
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC3 citations73
US9988386B2Jun 5, 2018
Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereof
KALA PHARMACEUTICALS INC3 citations73
US9861634B2Jan 9, 2018
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC2 citations73
US9827248B2Nov 28, 2017
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC2 citations73
US11369611B2Jun 28, 2022
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations62
US10966987B2Apr 6, 2021
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations62
US10954244B2Mar 23, 2021
Compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations62
US10544151B2Jan 28, 2020
Compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations52
US10351570B2Jul 16, 2019
Compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations52
US10285991B2May 14, 2019
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations52
US9833453B2Dec 5, 2017
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations52
US9695184B2Jul 4, 2017
Therapeutic compounds and uses thereof
KALA PHARMACEUTICALS INC0 citations52
MERCK & CO INC
10 patentsUS6017926AJan 25, 2000
Integrin receptor antagonists
MERCK & CO INC108 citations98
US6048861AApr 11, 2000
Integrin receptor antagonists
MERCK & CO INC100 citations97
US6784190B2Aug 31, 2004
Integrin receptor antagonists
MERCK & CO INC17 citations92
US6232308B1May 15, 2001
Bezazepine derivatives as αv integrin receptor antagonists
MERCK & CO INC34 citations92
US5981546ANov 9, 1999
Integrin antagonists
MERCK & CO INC45 citations92
US6211184B1Apr 3, 2001
Integrin antagonists
MERCK & CO INC21 citations91
US6413955B1Jul 2, 2002
Integrin receptor antagonists
MERCK & CO INC17 citations84
US7153862B2Dec 26, 2006
αv integrin receptor antagonists
MERCK & CO INC10 citations73
US5852045ADec 22, 1998
Fibrinogen receptor antagonists
MERCK & CO INC15 citations72
US6693101B2Feb 17, 2004
αv integrin receptor antagonists
MERCK & CO INC4 citations62
OCUTERRA THERAPEUTICS INC
5 patentsUS11685738B2Jun 27, 2023
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
OCUTERRA THERAPEUTICS INC1 citations72
US11685737B2Jun 27, 2023
Fluorinated integrin antagonists
OCUTERRA THERAPEUTICS INC2 citations71
US12497399B2Dec 16, 2025
Fluorinated integrin antagonists
OCUTERRA THERAPEUTICS INC0 citations61
US12286432B2Apr 29, 2025
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
OCUTERRA THERAPEUTICS INC0 citations61
US11858900B2Jan 2, 2024
Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives
OCUTERRA THERAPEUTICS INC0 citations50